When drug maker Allergan came out with the new eyelash thickening drug Latisse last year, it put on a marketing blitz featuring actress Brooke Shields. The Latisse Web site showed her longer, thicker lashes from the drug.
But the site barely mentioned Latisse's nasty side effects, which can include hair growth outside of the treatment area, a permanent darkening of eye color and bacterial infections that can lead to blindness.
The Food and Drug Administration lashed out in September 2009. In an official warning letter the FDA scolded Allergan ( AGN - news -people ) for its "misleading" claims about Latisse, which it said "omit and minimize" the drug's side effects. It demanded the company fix the Web site immediately. (Más...)
http://www.forbes.com/2010/02/02/drug-advertising-lipitor-lifestyle-health-pharmace
http://pharmacoserias.blogspot.com/2007/02/fda-ten-misleading-drug-ads.html
No comments:
Post a Comment